Single Ascending Dose Study of ANX105

NCT05288881 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: ANX105
DRUG: Placebo

Sponsor

Annexon, Inc.